ReviewJournal of pain research2026
Novel Insights into the Management of Painful Trigeminal Neuropathy: Targeting Peripheral and Central Pathomechanisms.
Review in Journal of pain research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Painful trigeminal neuropathy (PTN) is a very disabling but often unrecognized facial pain from various etiologies. Patients with PTN suffer from persistent, intense facial pain with significantly impaired sensory function in the trigeminal territories. This article reviews the anatomy and pathophysiology of PTN, as well as its clinical presentation and management. The peripheral inflammatory cascades, including immune cell activation, inflammatory mediator-induced nociceptor activation, and sensory hyperexcitability in the trigeminal nerve, are discussed, as are the central sensitization processes, including postsynaptic NMDA receptor activation, glial cell-mediated inflammation, and reduced inhibitory pathways in the central nervous system. A comprehensive literature review that covers multiple specialties and discusses various treatment options based on the available evidence is presented. Collectively, a practical algorithm is proposed to improve current PTN management. It provides novel guidance for managing PTN in an evidence-based, integrative, and mechanism-specific approach. In conclusion, a multidisciplinary team approach targeting both peripheral and central sensitization would be an ideal strategy for delivering optimal, mechanism-specific management in painful trigeminal neuropathy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.